Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring

[1]  R. Schmieder,et al.  Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study. , 2013, International journal of cardiology.

[2]  M. Epstein,et al.  Hypertension and chronic kidney disease progression: why the suboptimal outcomes? , 2012, The American journal of medicine.

[3]  P. Anyfanti,et al.  Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. , 2012, Journal of hypertension.

[4]  G. Mancia,et al.  The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation. , 2012, The Canadian journal of cardiology.

[5]  E. O’Brien,et al.  Significance of White-Coat Hypertension in Older Persons With Isolated Systolic Hypertension: A Meta-Analysis Using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Population , 2012, Hypertension.

[6]  Geoffrey A Head,et al.  Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement , 2012, Journal of hypertension.

[7]  Bryan Williams,et al.  Management of hypertension: summary of NICE guidance , 2011, BMJ : British Medical Journal.

[8]  Giuseppe Conte,et al.  Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. , 2011, Archives of internal medicine.

[9]  J. Banegas,et al.  Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring , 2011, Hypertension.

[10]  H. Krum,et al.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.

[11]  P. Sager,et al.  Divergent Results Using Clinic and Ambulatory Blood Pressures: Report of a Darusentan-Resistant Hypertension Trial , 2010, Hypertension.

[12]  R. Gabriel,et al.  Hipertensión arterial de bata blanca en ancianos. Análisis ecocardiográfico. Subestudio del proyecto EPICARDIAN , 2010 .

[13]  C. Agyemang,et al.  Masked Hypertension: Evidence of the Need to Treat , 2010, Current hypertension reports.

[14]  J. Schwartz,et al.  Changes in Home Versus Clinic Blood Pressure With Antihypertensive Treatments: A Meta-Analysis , 2008, Hypertension.

[15]  Pierre-François Plouin,et al.  Masked hypertension: a systematic review. , 2008, Journal of hypertension.

[16]  R. Fagard,et al.  Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis , 2007, Journal of hypertension.

[17]  Wei Li,et al.  Comparison of clinic and ambulatory blood pressure in response to antihypertensive drugs in Chinese patients. , 2007, Biomedical and environmental sciences : BES.

[18]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[19]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[20]  J. Banegas,et al.  Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20 000-patient database in Spain , 2007, Journal of hypertension.

[21]  Alice Stanton,et al.  Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study , 2005, Hypertension.

[22]  Roberto Sega,et al.  Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study , 2005, Circulation.

[23]  M. Edwards,et al.  Trial , 2004, The Lancet.

[24]  G. Parati,et al.  Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis , 2004, Journal of hypertension.

[25]  Peter W de Leeuw,et al.  Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. , 2003, The New England journal of medicine.

[26]  KristinaBjörklund,et al.  Isolated Ambulatory Hypertension Predicts Cardiovascular Morbidity in Elderly Men , 2003 .

[27]  Paul A. Smith,et al.  Sympathetic neural mechanisms in white-coat hypertension. , 2002, Journal of the American College of Cardiology.

[28]  Gianfranco Parati,et al.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. , 1999 .

[29]  G Parati,et al.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. , 1999, JAMA.

[30]  R. Holman,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .

[31]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[32]  J. Staessen,et al.  Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy , 1997, Journal of hypertension.

[33]  E. O’Brien,et al.  Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. , 1997, JAMA.

[34]  Giuseppe Mancia,et al.  Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy , 1997 .

[35]  K. Shimada,et al.  [White coat hypertension in the elderly]. , 1992, Nihon rinsho. Japanese journal of clinical medicine.

[36]  F. Cuccurullo,et al.  Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. , 2011, American journal of hypertension.

[37]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[38]  R. Gabriel,et al.  White-coat hypertension in the elderly. Echocardiographic analysis. A substudy of the EPICARDIAN project. , 2010, Revista espanola de cardiologia.

[39]  G Mancia,et al.  Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. , 1997, Circulation.